(Q42674160)

English

Immunogenicity, safety, and efficacy of abatacept administered subcutaneously with or without background methotrexate in patients with rheumatoid arthritis: results from a phase III, international, multicenter, parallel-arm, open-label study

scientific article published on May 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Immunogenicity, safety, and efficacy of abatacept administered subcutaneously with or without background methotrexate in patients with rheumatoid arthritis: results from a phase III, international, multicenter, parallel-arm, open-label study (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

multicenter clinical trial

0 references

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Peter Nash

1

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Sauithree Nayiager

2

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Mark C Genovese

3

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Alan J Kivitz

4

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Kurt Oelke

5

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Charles Ludivico

6

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

William Palmer

7

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Cristian Rodriguez

8

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Ingrid Delaet

9

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Ayanbola Elegbe

10

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Michael Corbo

11

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

publication date

1 May 2013

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Arthritis Care and Research

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

65

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

718-728

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Immunogenicity of therapeutic proteins

1 reference

https://api.crossref.org/works/10.1002%2FACR.21876

21 January 2018

Development of antidrug antibodies against adalimumab and association with disease activity and treatment failure during long-term follow-up

1 reference

https://api.crossref.org/works/10.1002%2FACR.21876

21 January 2018

Mechanisms of differential immunogenicity of tumor necrosis factor inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FACR.21876

21 January 2018

Immediate adverse reactions to biologicals: from pathogenic mechanisms to prophylactic management

1 reference

https://api.crossref.org/works/10.1002%2FACR.21876

21 January 2018

Predictors of response to methotrexate in early DMARD naive rheumatoid arthritis: results from the initial open-label phase of the SWEFOT trial.

1 reference

https://api.crossref.org/works/10.1002%2FACR.21876

21 January 2018

Safety and efficacy of the selective costimulation modulator abatacept in patients with rheumatoid arthritis receiving background methotrexate: a 5-year extended phase IIB study

1 reference

https://api.crossref.org/works/10.1002%2FACR.21876

21 January 2018

Efficacy and safety of the selective co-stimulation modulator abatacept following 2 years of treatment in patients with rheumatoid arthritis and an inadequate response to anti-tumour necrosis factor therapy

1 reference

https://api.crossref.org/works/10.1002%2FACR.21876

21 January 2018

Subcutaneous abatacept versus intravenous abatacept: a phase IIIb noninferiority study in patients with an inadequate response to methotrexate.

1 reference

https://api.crossref.org/works/10.1002%2FACR.21876

21 January 2018

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FACR.21876

21 January 2018

Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states

1 reference

https://api.crossref.org/works/10.1002%2FACR.21876

21 January 2018

The Simplified Disease Activity Index and Clinical Disease Activity Index to monitor patients in standard clinical care

1 reference

https://api.crossref.org/works/10.1002%2FACR.21876

21 January 2018

Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FACR.21876

21 January 2018

Evaluation of abatacept administered subcutaneously in adults with active rheumatoid arthritis: impact of withdrawal and reintroduction on immunogenicity, efficacy and safety (phase Iiib ALLOW study).

1 reference

https://api.crossref.org/works/10.1002%2FACR.21876

21 January 2018

Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: a randomized trial.

1 reference

https://api.crossref.org/works/10.1002%2FACR.21876

21 January 2018

Abatacept in subjects who switch from intravenous to subcutaneous therapy: results from the phase IIIb ATTUNE study

1 reference

https://api.crossref.org/works/10.1002%2FACR.21876

21 January 2018

Tumor necrosis factor alpha drugs in rheumatoid arthritis: systematic review and metaanalysis of efficacy and safety

1 reference

https://api.crossref.org/works/10.1002%2FACR.21876

21 January 2018

Cutaneous side effects of anti-tumor necrosis factor biologic therapy: a clinical review

1 reference

https://api.crossref.org/works/10.1002%2FACR.21876

21 January 2018

Identifiers

10.1002/ACR.21876

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42674160&oldid=2160059144"